Bardy Diagnostics Funding: $375M Raised, Series B (2019)
Bardy Diagnostics is based in New Providence, NJ. It has raised $375M in total funding. Latest round: Series B.
Bardy Diagnostics funding overview
Bardy Diagnostics is based in New Providence, NJ. Bardy Diagnostics has raised $375M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in April 2019. The round record for Bardy Diagnostics runs through 2019; nothing later has been disclosed. Investors on record include River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures and 3 others. 9 distinct backers are named across the disclosed rounds.
Bardy Diagnostics at a glance
Total raised
$375M
Latest round
Series B
Latest round date
April 2019
Headquarters
New Providence, NJ
Notable investors
River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures, SV Health Investors, Health Enterprise Partners
Frequently asked about Bardy Diagnostics funding
How much has Bardy Diagnostics raised?
Bardy Diagnostics has raised $375M in total disclosed funding across the rounds on record.
Who has invested in Bardy Diagnostics?
River Cities Capital Funds, HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures are named among the investors backing Bardy Diagnostics.
What was the latest Bardy Diagnostics funding round?
The most recent disclosed round is a Series B, announced in April 2019.
Where is Bardy Diagnostics based?
Bardy Diagnostics is based in New Providence, NJ.
When did Bardy Diagnostics last raise?
The last disclosed Bardy Diagnostics round closed in April 2019 at Series B.
Totals shown for Bardy Diagnostics aggregate every disclosed round on file. To see how that compares, browse the companies in New Providence and the investors behind them below.
